Table 1.
Total (N = 25) | |
---|---|
Age | 59.4 ± 15 |
Sex (male) | 12 (52%) |
Hematocrit [%] | 42.0 ± 4.7 |
LV-EDVi [mL/m²] | 73.0 ± 13.3 |
LV-EF [%] | 60.0 ± 6.8 |
RV-EDVi [mL/m²] | 73.6 ± 14.0 |
RV-EF [%] | 56.3 ± 8.4 |
Native | |
HR [s−1] | 67.8 ± 9.2 |
T1 myo [ms] | 1256 ± 39 |
T1 blood [ms] | 1859 ± 85 |
Half dose (0.05 mmol/kg) | |
HR [s−1] | 73.6 ± 8.3 |
dT [mm:ss] | 10:15 ± 02:06 |
T1 myo [ms] | 786.6 ± 51.7 |
T1 blood [ms] | 654 ± 74 |
ECV [%] | 27.6 ± 3.1 |
Full dose (0.1 mmol/kg) | |
HR [s−1] | 72.7 ± 7.6 |
dT [mm:ss] | 10:54 ± 2:10 |
T1 myo [ms] | 608 ± 39 |
T1 blood [ms] | 422 ± 48 |
ECV [%] | 26.7 ± 2.7 |
Myocardial (myo) and blood pool (blood) T1 relaxation times before contrast application (native), after the first perfusion (half dose, 0.05 mmol/kg), and after the second perfusion (full dose, total of 0.1 mmol/kg). dT time between the perfusion scan and the T1 mapping scan, ECV extracellular volume, HR heart rate. Continuous values as mean ± standard deviation, nominal values as number and percentage. T1 mapping and ECV mean of both readers.